United States Percutaneous Transluminal Angioplasty Market Research Report Forecast 2017-2021

March 2017 | 114 pages | ID: U0BD06C5BB6EN
S&P Consulting

Abstracts

The United States Percutaneous Transluminal Angioplasty Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Percutaneous Transluminal Angioplasty industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Percutaneous Transluminal Angioplasty market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

• Acrostak (Schweiz) AG
• Concept Medical Inc
• Lifetech Scientific
• Micell Technologies, Inc
• SurModics, Inc.
• The Spectranetics Corporation
• Vascular Nanotransfer Technologies Company
• company 8
• company 9

United States Percutaneous Transluminal Angioplasty Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Percutaneous Transluminal Angioplasty Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY MARKET OVERVIEW

1.1 Product Overview and Scope of Percutaneous Transluminal Angioplasty
1.2 Percutaneous Transluminal Angioplasty Market Segmentation by Type
  1.2.1 United States Production Market Share of Percutaneous Transluminal Angioplasty by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Percutaneous Transluminal Angioplasty Market Segmentation by Application
  1.3.1 Percutaneous Transluminal Angioplasty Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Percutaneous Transluminal Angioplasty (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY MARKET COMPETITION BY MANUFACTURERS

3.1 United States Percutaneous Transluminal Angioplasty Production and Share by Manufacturers (2015 and 2016)
3.2 United States Percutaneous Transluminal Angioplasty Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Percutaneous Transluminal Angioplasty Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Percutaneous Transluminal Angioplasty Manufacturing Base Distribution, Production Area and Product Type
3.5 Percutaneous Transluminal Angioplasty Market Competitive Situation and Trends
  3.5.1 Percutaneous Transluminal Angioplasty Market Concentration Rate
  3.5.2 Percutaneous Transluminal Angioplasty Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Percutaneous Transluminal Angioplasty Production and Market Share by Type (2012-2017)
4.2 United States Percutaneous Transluminal Angioplasty Revenue and Market Share by Type (2012-2017)
4.3 United States Percutaneous Transluminal Angioplasty Price by Type (2012-2017)
4.4 United States Percutaneous Transluminal Angioplasty Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY MARKET ANALYSIS BY APPLICATION

5.1 United States Percutaneous Transluminal Angioplasty Consumption and Market Share by Application (2012-2017)
5.2 United States Percutaneous Transluminal Angioplasty Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY MANUFACTURERS ANALYSIS

6.1 Acrostak (Schweiz) AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Concept Medical Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Lifetech Scientific
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Micell Technologies, Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 SurModics, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 The Spectranetics Corporation
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Vascular Nanotransfer Technologies Company
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 company
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY MANUFACTURING COST ANALYSIS

7.1 Percutaneous Transluminal Angioplasty Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Percutaneous Transluminal Angioplasty

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Percutaneous Transluminal Angioplasty Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Percutaneous Transluminal Angioplasty Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY MARKET FORECAST (2017-2021)

11.1 United States Percutaneous Transluminal Angioplasty Production, Revenue Forecast (2017-2021)
11.2 United States Percutaneous Transluminal Angioplasty Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Percutaneous Transluminal Angioplasty Production Forecast by Type (2017-2021)
11.4 United States Percutaneous Transluminal Angioplasty Consumption Forecast by Application (2017-2021)
11.5 Percutaneous Transluminal Angioplasty Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES
Figure Picture of Percutaneous Transluminal Angioplasty
Table Classification of Percutaneous Transluminal Angioplasty
Figure United States Sales Market Share of Percutaneous Transluminal Angioplasty by Type in 2015
Table Application of Percutaneous Transluminal Angioplasty
Figure United States Sales Market Share of Percutaneous Transluminal Angioplasty by Application in 2015
Figure United States Percutaneous Transluminal Angioplasty Sales and Growth Rate (2011-2021)
Figure United States Percutaneous Transluminal Angioplasty Revenue and Growth Rate (2011-2021)
Table United States Percutaneous Transluminal Angioplasty Sales of Key Manufacturers (2015 and 2016)
Table United States Percutaneous Transluminal Angioplasty Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Percutaneous Transluminal Angioplasty Sales Share by Manufacturers
Figure 2016 Percutaneous Transluminal Angioplasty Sales Share by Manufacturers
Table United States Percutaneous Transluminal Angioplasty Revenue by Manufacturers (2015 and 2016)
Table United States Percutaneous Transluminal Angioplasty Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Percutaneous Transluminal Angioplasty Revenue Share by Manufacturers
Table 2016 United States Percutaneous Transluminal Angioplasty Revenue Share by Manufacturers
Table United States Market Percutaneous Transluminal Angioplasty Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Percutaneous Transluminal Angioplasty Average Price of Key Manufacturers in 2015
Figure Percutaneous Transluminal Angioplasty Market Share of Top 3 Manufacturers
Figure Percutaneous Transluminal Angioplasty Market Share of Top 5 Manufacturers
Table United States Percutaneous Transluminal Angioplasty Sales by Type (2012-2017)
Table United States Percutaneous Transluminal Angioplasty Sales Share by Type (2012-2017)
Figure United States Percutaneous Transluminal Angioplasty Sales Market Share by Type in 2015
Table United States Percutaneous Transluminal Angioplasty Revenue and Market Share by Type (2012-2017)
Table United States Percutaneous Transluminal Angioplasty Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Percutaneous Transluminal Angioplasty by Type (2012-2017)
Table United States Percutaneous Transluminal Angioplasty Price by Type (2012-2017)
Figure United States Percutaneous Transluminal Angioplasty Sales Growth Rate by Type (2012-2017)
Table United States Percutaneous Transluminal Angioplasty Sales by Application (2012-2017)
Table United States Percutaneous Transluminal Angioplasty Sales Market Share by Application (2012-2017)
Figure United States Percutaneous Transluminal Angioplasty Sales Market Share by Application in 2015
Table United States Percutaneous Transluminal Angioplasty Sales Growth Rate by Application (2012-2017)
Figure United States Percutaneous Transluminal Angioplasty Sales Growth Rate by Application (2012-2017)
Table Acrostak (Schweiz) AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Acrostak (Schweiz) AG Percutaneous Transluminal Angioplasty Production, Revenue, Price and Gross Margin (2012-2017)
Table Acrostak (Schweiz) AG Percutaneous Transluminal Angioplasty Market Share (2012-2017)
Table Concept Medical Inc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Concept Medical Inc Percutaneous Transluminal Angioplasty Production, Revenue, Price and Gross Margin (2012-2017)
Table Concept Medical Inc Percutaneous Transluminal Angioplasty Market Share (2012-2017)
Table Lifetech Scientific Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Lifetech Scientific Percutaneous Transluminal Angioplasty Production, Revenue, Price and Gross Margin (2012-2017)
Table Lifetech Scientific Percutaneous Transluminal Angioplasty Market Share (2012-2017)
Table Micell Technologies, Inc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Micell Technologies, Inc Percutaneous Transluminal Angioplasty Production, Revenue, Price and Gross Margin (2012-2017)
Table Micell Technologies, Inc Percutaneous Transluminal Angioplasty Market Share (2012-2017)
Table SurModics, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table SurModics, Inc. Percutaneous Transluminal Angioplasty Production, Revenue, Price and Gross Margin (2012-2017)
Table SurModics, Inc. Percutaneous Transluminal Angioplasty Market Share (2012-2017)
Table The Spectranetics Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors
Table The Spectranetics Corporation Percutaneous Transluminal Angioplasty Production, Revenue, Price and Gross Margin (2012-2017)
Table The Spectranetics Corporation Percutaneous Transluminal Angioplasty Market Share (2012-2017)
Table Vascular Nanotransfer Technologies Company Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vascular Nanotransfer Technologies Company Percutaneous Transluminal Angioplasty Production, Revenue, Price and Gross Margin (2012-2017)
Table Vascular Nanotransfer Technologies Company Percutaneous Transluminal Angioplasty Market Share (2012-2017)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Percutaneous Transluminal Angioplasty Production, Revenue, Price and Gross Margin (2012-2017)
Table company 8 Percutaneous Transluminal Angioplasty Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Percutaneous Transluminal Angioplasty Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Percutaneous Transluminal Angioplasty Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Percutaneous Transluminal Angioplasty
Figure Manufacturing Process Analysis of Percutaneous Transluminal Angioplasty
Figure Percutaneous Transluminal Angioplasty Industrial Chain Analysis
Table Raw Materials Sources of Percutaneous Transluminal Angioplasty Major Manufacturers in 2015
Table Major Buyers of Percutaneous Transluminal Angioplasty
Table Distributors/Traders List
Figure United States Percutaneous Transluminal Angioplasty Production and Growth Rate Forecast (2017-2021)
Figure United States Percutaneous Transluminal Angioplasty Revenue and Growth Rate Forecast (2017-2021)
Table United States Percutaneous Transluminal Angioplasty Production Forecast by Type (2017-2021)
Table United States Percutaneous Transluminal Angioplasty Consumption Forecast by Application (2017-2021)